You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Topic 380- QIDS: Using Radiomics to Impact Radiotherapy Treatment Planning- Moonshot
SBC: HealthMyne, Inc. Topic: NCIHealthMyne proposes developing a Clinical Decision Support tool to be used in the point-of-care workflow for the Radiation Oncologist that uses radiomic features that have evidence-based association to disease course and/or normal organ damage, in order to impact the treatment planning process. Phase 1 will focus on extraction, calculation, and validation of identified radiomic features for lung c ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Computerized Screening for Comorbidity in Adolescents with Substance or Psychiatric Disorders
SBC: KOBAK, KENNETH A Topic: 104Project Summary This is a supplementalrenewalgrant to the Phase II SBIR grantComputerized Screening for Comorbidity in Adolescents with Substance or Psychiatric DisordersSince the funding of the Phase I granttwo significant developments occurred in the fieldthe American Psychiatric Association s release of the DSMmanualand NIMH s launch of the Research Domain CriteriaRDoCinitiative that aims to cr ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of a cell based assay to assess antigen specific tolerance
SBC: SALUS DISCOVERY LLC Topic: RProject Summary Despite advances in the field of transplantation that have curbed acute rejection through immunosuppressive drugs and better control of infection and ischemia reperfusion injurychronic allograft rejection is still a major obstacle for successful organ transplantationSuccessful organ transplantation appears to require a balanced function of effector and regulatory T cellsTregto prev ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Synthetic hydrogels for biomanufacturing of iPSC-derived neural cells for precision medicine
SBC: STEM PHARM, INCORPORATED Topic: 106Project Summary Abstract Human neural cells manufactured using patient derived induced pluripotent stem cellsiPSCshold great promise for modeling neurodevelopmental disordersdiscovering new precision therapiesand screening for potential risks from environmental toxinsHoweverbiomanufacturing of neural cells and tissues is severely limited by low efficiencypoor reproducibilityand extended timeframes ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Development of a novel highly effective influenza vaccine
SBC: FLUGEN INC Topic: NIAIDSeasonal influenzafluvirusan NIAID category C priority pathogencauses widespread infectionresulting in at leastmillion cases of severe illness anddeaths worldwideWhile annual vaccination is recommended for all individuals aged overmonths in the UScurrent vaccines are only aroundeffective and there is an urgent need for safemore effective influenza vaccines that offer broad spectrum protectionTo me ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
RAPID: An Extremely Fast Monte Carlo Dose Computing Software for Nuclear Medicine
SBC: VOXIMETRY INC Topic: 100PROJECT SUMMARY and ABSTRACT The clinical outcome of radiation therapy depends on delivering the highest possible absorbed dose to the tumor swhile limiting the dose to normal tissuesUnfortunatelyunlike external beam radiotherapyEBRTcurrent RT prescription methods do not consider absorbed dose to individual patients but instead use empirically derived or standard methodsThusup toof these patients ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Novel Myeloperoxidase Inhibitor for Treating Multiple Sclerosis
SBC: ReNeuroGen LLC Topic: 102Abstract Multiple sclerosisMSis an inflammatory demyelinating disease of the central nervous systemCNSIt is the most common autoimmune disease affecting the CNSAlthough much attention has focused on the immunological mechanisms in MSnew evidence suggests that oxidative stress also induces MS neuropathologyMyeloperoxidaseMPOis a powerful peroxidative enzyme that has long been considered a therapeut ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
Selection and Development of a Lead Biologic for Treating Mitochondrial Disorders
SBC: CYTEGEN CORP Topic: NIAProject Summary Abstract Mitochondrial dysfunction causes mitochondrial diseases and is tightly linked to aging and neurodegenerative disorders such as Parkinsonandapos s and Alzheimerandapos sRecent discoveries support that mitochondrial dysfunction can be overcome to treat age related declineCyteGenandapos s hypothesis is that exercise induces the secretion of bloodborne proteins that act system ...
STTR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health -
A Direct-Reading Liquid Crystal Based Formaldehyde Dosimeter for Personal Exposure Monitoring
SBC: Platypus Technologies, LLC Topic: NIEHSPlatypus Technologies aims to advance the liquid crystalLCbased molecular analytic detection of formaldehyde that it established with SBIR Phase I support to complete the development and integrate its innovative LC based technology into product forms for rapid identification of formaldehyde emissions for short term and time weighted exposureTWAFormaldehyde is a known carcinogenand workplace exposu ...
SBIR Phase II 2018 Department of Health and Human ServicesNational Institutes of Health -
A 3-month Release Naltrexone for Addiction Treatment
SBC: Plumb Pharmaceuticals LLC Topic: NIDAOpioid misuse is a world wide problemand it is increasingThe epidemic has shifted from a problem largely confined to urban areas to one that is both urban and ruralMaintenance therapy helps alleviate situational cravings and makes addiction therapy more effectivebut methadone clinics are largely confined to larger citiesbuprenorphine must be prescribed by physicians with a specific waiverand it ma ...
SBIR Phase I 2018 Department of Health and Human ServicesNational Institutes of Health